Chapter 15. The Safety of Medical Products

  1. John P Griffin BSc, PhD, MBBS, FRCP, FRCPath, FFPM1,
  2. John O'Grady MD, FRCP, FFPM, FBIRA, MRCPath2
  1. A Peter Fletcher,
  2. Susan Shaw

Published Online: 25 OCT 2007

DOI: 10.1002/9780470987391.ch15

The Textbook of Pharmaceutical Medicine, Fifth Edition

The Textbook of Pharmaceutical Medicine, Fifth Edition

How to Cite

Fletcher, A. P. and Shaw, S. (2007) The Safety of Medical Products, in The Textbook of Pharmaceutical Medicine, Fifth Edition (eds J. P. Griffin and J. O'Grady), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987391.ch15

Editor Information

  1. 1

    Director, Asklepieion Consultancy Ltd., Visiting Professor, University of Surrey Postgraduate Medical School, Former Director, Association of the British Pharmaceutical Industry, London, Formerly Professional Head of the Medicines Division, DHSS, London

  2. 2

    Visiting Professor of Clinical Pharmacology, University of London

Publication History

  1. Published Online: 25 OCT 2007
  2. Published Print: 15 DEC 2005

ISBN Information

Print ISBN: 9780727918406

Online ISBN: 9780470987391

SEARCH

Keywords:

  • product safety;
  • clinical medicine;
  • adverse drug reactions;
  • COX 2 inhibitor;
  • committee on safety of medicines

Summary

This chapter contains sections titled:

  • Introduction

  • The Concept of Safety

  • General Considerations

  • Methods of Postmarketing Safety Evaluation

  • Clinical Trials

  • Spontaneous Event Reporting

  • Computerised Databases

  • Case-Control Studies

  • Prescription Event Monitoring

  • Some Examples

  • Causality Assessment

  • The Legal Framework and its Implications for Future International Developments

  • Other Considerations and Conclusions